- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
People
Bob Cooper's extensive experience includes representing clients in complex commercial litigation and governmental investigations, conducting internal investigations, and counseling global companies on their most challenging and significant business issues. His particular expertise in antitrust and competition matters leads clients to seek his judgment and strategic advice on mergers, acquisitions and other business transactions. Bob also regularly advises clients on dealings with competitors, suppliers and customers.
Bob has represented clients in a wide variety of industries, including airlines, agribusiness, banking, biotechnology, commercial real estate, healthcare, health insurance, healthcare technology, insurance/reinsurance, Internet, payment systems, private equity, sports media, telecommunications, and telehealth. He has served as lead counsel or co-lead counsel before a number of federal and state courts, in arbitration proceedings and mediations, and before the United States Department of Justice, the Federal Trade Commission, the Federal Communications Commission, the Securities and Exchange Commission and numerous state Attorneys General.
Credentials
J.D., Emory University School of Law, with distinction
B.A., Columbia University
District of Columbia
Supreme Court of the United States
U.S. Court of Appeals for the D.C. Circuit
U.S. Court of Appeals for the Eighth Circuit
U.S. District Court for the District of Columbia
Law Clerk, Hon. William C. O'Kelley, U.S. District Court for the Northern District of Georgia
American Bar Association
The Economic Club of Washington D.C.
News
In the News · Source: RIA Intel
December 15, 2020
Bob Cooper discusses the Biden Administration’s approach to noncompete and no-poach clauses that are ubiquitous in financial advisory contracts
In the News · Source: American Banker
December 2, 2020
Bob Cooper discusses antitrust enforcement in a wide-ranging interview on the American Banker’s Bankshot podcast
In the News · Source: Global Competition Review
October 30, 2020
Robert Cooper advises Sanford Health on its merger with Intermountain Healthcare
Matters
Lead an internal investigation for a major biotechnology company
Served as lead trial and appellate counsel in the FTC's challenge to a regional health system's proposed acquisition of a multi-specialty physician practice
Lead defense of six companies in litigation alleging breach of licensing agreements and prosecution of antitrust counterclaims (confidential settlement)
See more
Close
Matters
Lead an internal investigation for a major biotechnology company
Served as lead trial and appellate counsel in the FTC's challenge to a regional health system's proposed acquisition of a multi-specialty physician practice
Lead defense of six companies in litigation alleging breach of licensing agreements and prosecution of antitrust counterclaims (confidential settlement)
Obtained antitrust clearance for multiple transactions in various industries, including healthcare, assisted living and commercial and private aviation
Represented several integrated health systems in connection with competition and related issues
Represented a major healthcare technology company in connection with numerous competition and strategic issues
Represented a global Internet service provider on competition and regulatory issues in the U.S. and Europe, and before the DOJ and FCC in connection with several telecom and media mergers
Served as co-lead trial counsel in defending a Fortune 100 company in a multi-hundred million-dollar arbitration alleging breach of a technology licensing agreement and tortious interference (no relief awarded to claimants)
Represented a leading payment card network in antitrust litigation against its principal competitors (client obtained a settlement in excess of $4 billion)
Defended a leading payment card network against claims by the Department of Justice and various merchants (both a class and opt outs) alleging violations of Sections 1 and 2 of the Sherman Act
Represented a Chinese manufacturer in connection with U.S. antitrust issues associated with the acquisition of a competitor
Represented an international private equity firm in an SEC investigation
Defended a global airline in connection with private litigation challenging a merger with another global carrier, and represented that airline in connection with the DOJ's review of the merger
Lead an internal investigation for a Bermuda-based reinsurer, and represented the non-executive members of the Board in connection with related governmental investigations
Insights
Client Alert
February 24, 2021
Buyers Beware: An Increased Risk of Private Merger Challenges
Client Alert
January 25, 2021
Not So Special – Securities And Antitrust Regulators May Increase Attention To SPACs In The Coming Year
Client Alert
January 4, 2021
Congress Restores Application of Federal Antitrust Laws to Health Insurers
News
In the News · Source: RIA Intel
December 15, 2020
Bob Cooper discusses the Biden Administration’s approach to noncompete and no-poach clauses that are ubiquitous in financial advisory contracts
In the News · Source: American Banker
December 2, 2020
Bob Cooper discusses antitrust enforcement in a wide-ranging interview on the American Banker’s Bankshot podcast
In the News · Source: Global Competition Review
October 30, 2020
Robert Cooper advises Sanford Health on its merger with Intermountain Healthcare
Matters
Lead an internal investigation for a major biotechnology company
Served as lead trial and appellate counsel in the FTC's challenge to a regional health system's proposed acquisition of a multi-specialty physician practice
Lead defense of six companies in litigation alleging breach of licensing agreements and prosecution of antitrust counterclaims (confidential settlement)
See more
Close
Matters
Lead an internal investigation for a major biotechnology company
Served as lead trial and appellate counsel in the FTC's challenge to a regional health system's proposed acquisition of a multi-specialty physician practice
Lead defense of six companies in litigation alleging breach of licensing agreements and prosecution of antitrust counterclaims (confidential settlement)
Obtained antitrust clearance for multiple transactions in various industries, including healthcare, assisted living and commercial and private aviation
Represented several integrated health systems in connection with competition and related issues
Represented a major healthcare technology company in connection with numerous competition and strategic issues
Represented a global Internet service provider on competition and regulatory issues in the U.S. and Europe, and before the DOJ and FCC in connection with several telecom and media mergers
Served as co-lead trial counsel in defending a Fortune 100 company in a multi-hundred million-dollar arbitration alleging breach of a technology licensing agreement and tortious interference (no relief awarded to claimants)
Represented a leading payment card network in antitrust litigation against its principal competitors (client obtained a settlement in excess of $4 billion)
Defended a leading payment card network against claims by the Department of Justice and various merchants (both a class and opt outs) alleging violations of Sections 1 and 2 of the Sherman Act
Represented a Chinese manufacturer in connection with U.S. antitrust issues associated with the acquisition of a competitor
Represented an international private equity firm in an SEC investigation
Defended a global airline in connection with private litigation challenging a merger with another global carrier, and represented that airline in connection with the DOJ's review of the merger
Lead an internal investigation for a Bermuda-based reinsurer, and represented the non-executive members of the Board in connection with related governmental investigations
Insights
Client Alert
February 24, 2021
Buyers Beware: An Increased Risk of Private Merger Challenges
Client Alert
January 25, 2021
Not So Special – Securities And Antitrust Regulators May Increase Attention To SPACs In The Coming Year
Client Alert
January 4, 2021
Congress Restores Application of Federal Antitrust Laws to Health Insurers
News
In the News · Source: RIA Intel
December 15, 2020
Bob Cooper discusses the Biden Administration’s approach to noncompete and no-poach clauses that are ubiquitous in financial advisory contracts
In the News · Source: American Banker
December 2, 2020
Bob Cooper discusses antitrust enforcement in a wide-ranging interview on the American Banker’s Bankshot podcast
In the News · Source: Global Competition Review
October 30, 2020
Robert Cooper advises Sanford Health on its merger with Intermountain Healthcare
Credentials
J.D., Emory University School of Law, with distinction
B.A., Columbia University
District of Columbia
Supreme Court of the United States
U.S. Court of Appeals for the D.C. Circuit
U.S. Court of Appeals for the Eighth Circuit
U.S. District Court for the District of Columbia
Law Clerk, Hon. William C. O'Kelley, U.S. District Court for the Northern District of Georgia
American Bar Association
The Economic Club of Washington D.C.